abiraterone,olaparib
astrazeneca,merck
['crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'gu ']
#gu23 #ascogu all 3 parpi combo trials in l1 mcrpc are pointing to need for precision to max therapeutic index . so we agree to treat hrr+. now how to select winners from the hrr- group ? 
Genitourinary Oncology Section Chief Houston Methodist Cancer Center